Pharmacyte Biotech Inc (OTCMKTS:PMCB) is about to start Phase 2b human clinical trial in pancreatic cancer in some time. Before the trial begins, the company…
Pharmacyte Biotech Inc (OTCMKTS:PMCB) released an educational article that will allow people to know about its technology and its application in pancreatic…
Pharmacyte Biotech Inc (OTCMKTS:PMCB) has decided to discuss some of its major milestones right before the phase 2b clinical trial in pancreatic cancer…
Pharmacyte Biotech Inc (OTCMKTS:PMCB) may not be as large as many other biotech firms around the world, but the innovative technologies used by it are…
Pharmacyte Biotech Inc (OTCMKTS:PMCB) revealed that it finalized a contract with Imaging Endpoints in Arizona for completion of radiologic imaging process…